Tamoxifen, a selective estrogen receptor modulator (SERM), is widely used as an endocrine therapy for hormone-sensitive breast cancer, significantly reducing the risks of recurrence, breast cancer-related mortality, and overall mortality [2,3]. Here, ESR1 is linked to breast carcinoma.